(Q30623213)

25 June 2017

1 reference

title

Medication treatment in subjects with autistic spectrum disorders (English)

1 reference

25 June 2017

0 references

autism spectrum disorder

0 references

author name string

Buitelaar JK

series ordinal

1

1 reference

PubMed ID

11140783

25 June 2017

Willemsen-Swinkels SH

series ordinal

2

1 reference

PubMed ID

11140783

25 June 2017

language of work or name

1 reference

1 January 2000

1 reference

European Child & Adolescent Psychiatry

25 June 2017

1 reference

25 June 2017

9 Suppl 1

1 reference

25 June 2017

I85-97

1 reference

Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.

25 June 2017

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

The hyperserotonemia of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Autism as a strongly genetic disorder: evidence from a British twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A clinicopathological study of autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Brief report: neuroanatomic observations of the brain in pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A case-control family history study of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Association of tuberous sclerosis of temporal lobes with autism and atypical autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Sex reassignment of adolescent transsexuals: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Diagnostic rules for children with PDD-NOS and multiple complex developmental disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Exploring the boundaries of pervasive developmental disorder not otherwise specified: analyses of data from the DSM-IV Autistic Disorder Field Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Naltrexone in autistic children: behavioral symptoms and attentional learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Vaccine adverse events: causal or coincidental?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Fluoxetine Treatment of Children and Adults with Autistic Disorder and Mental Retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Evidence of linkage between the serotonin transporter and autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Cerebellar hypoplasia and hyperplasia in infantile autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Hypoplasia of Cerebellar Vermal Lobules VI and VII in Autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Abnormal intestinal permeability in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Low medial prefrontal dopaminergic activity in autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Brief report: neuroimaging in autism: the state of the science 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Use of risperidone in pervasive developmental disorders: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Infantile autism: a genetic study of 21 twin pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Neurohumoral brain dynamics of social group formation. Implications for autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Urinary homovanillic acid levels of autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Preliminary observations on the effect of fenfluramine on blood serotonin and symptoms in three autistic boys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

The treatment of epilepsy in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Childhood psychosis and monoamine metabolites in spinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Quantified multidimensional assessment of autism and other pervasive developmental disorders. Application for bioclinical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

The neuropsychology of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Case study: risperidone treatment of children and adolescents with developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Brainstem and cerebellar vermis involvement in autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Development of the brainstem and cerebellum in autistic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Serotonin and autism: biochemical and molecular biology features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Practitioner review: psychological and educational treatments for autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Absence of magnetic resonance imaging evidence of pontine abnormality in infantile autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A neurobiological basis of social attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A full genome screen for autism with evidence for linkage to a region on chromosome 7q. International Molecular Genetic Study of Autism Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Serotonin transporter (5-HTT) gene variants associated with autism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Infantile autism and affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Obstetric complications in autism: consequences or causes of the condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Brief report: a double-blind study of naltrexone in infantile autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Pathways to marijuana use among adolescents: cultural/ecological, family, peer, and personality influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Effects of tryptophan depletion in drug-free adults with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Clomipramine in autism: preliminary evidence of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Neurochemical study of dopamine functioning in autistic and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Whole blood serotonin and tryptophan in autism: temporal stability and the effects of medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A preliminary 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Plasma oxytocin levels in autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

An open trial of risperidone in young autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A neurochemical theory of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Regional brain enlargement in autism: a magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

An MRI study of the corpus callosum in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Magnetic resonance imaging evidence for a defect of cerebral cortical development in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Magnetic resonance imaging in autism: measurement of the cerebellum, pons, and fourth ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

An MRI study of autism: the cerebellum revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Autism: electroencephalogram abnormalities and clinical improvement with valproic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Use of methylphenidate in the treatment of children with autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Open trial effects of beta-blockers on speech and social behaviors in 8 autistic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Effects of fenfluramine on 14 outpatients with the syndrome of autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Autism and known medical conditions: myth and substance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A pilot study of clomipramine in young autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Genetic influences in childhood-onset psychiatric disorders: autism and attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

21 January 2018

Lessons from secretin.

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Plasma beta-endorphin concentrations in people with learning disability and self-injurious and/or autistic behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Placebo-controlled acute dosage naltrexone study in young autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Head circumference in autism and other pervasive developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

Delayed maturation of the frontal cortex in childhood autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS007870070022

The serotonin system in autism

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS007870070022

21 January 2018

12 December 2020

Naltrexone in young autistic children: replication study and learning measures.

1 reference

12 December 2020

Reduced brainstem size in children with autism

1 reference

12 December 2020

Catecholaminergic metabolism and autism.

1 reference

12 December 2020

Tardive and withdrawal dyskinesia in autistic children: a prospective study.

1 reference

12 December 2020

Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study

1 reference

12 December 2020

Macrocephaly in children and adults with autism.

1 reference

12 December 2020

Sertraline response in adults with mental retardation and autistic disorder.

1 reference

12 December 2020

An MRI study of brain size in autism.

1 reference

12 December 2020

Clinical effect of buspirone in autistic children.

1 reference

12 December 2020

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism

1 reference

12 December 2020

Behavioural techniques to reduce self-injurious behaviour in children with autism.

1 reference

12 December 2020

Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation

1 reference

12 December 2020

Fenfluramine: neurotoxicity.

1 reference

12 December 2020

A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using crossover design

1 reference

12 December 2020

Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons

1 reference

12 December 2020

The contribution of neuropathologic studies to the understanding of autism

1 reference

12 December 2020

Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism

1 reference

12 December 2020

Untoward effects of fenfluramine in autistic children.

1 reference

12 December 2020

Blood serotonin levels in severe mental retardation

1 reference

12 December 2020

Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives.

1 reference

12 December 2020

Self-injurious behaviour in retarded children: clinical phenomena and biological mechanisms.

1 reference

12 December 2020

Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology.

1 reference

12 December 2020

Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity

1 reference

12 December 2020

Pimozide in autistic children

1 reference

12 December 2020

Risperidone-induced hepatotoxicity?

1 reference

12 December 2020

Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study.

1 reference

12 December 2020

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

1 reference

12 December 2020

Case study: risperidone-induced hepatotoxicity in pediatric patients

1 reference

12 December 2020

Improved social and language skills after secretin administration in patients with autistic spectrum disorders

1 reference

12 December 2020

Identifiers

DOI

10.1007/S007870070022

1 reference

25 June 2017

1 reference

PubMed ID

11140783